317 related articles for article (PubMed ID: 28747065)
1. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
3. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
4. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
5. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
6. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
7. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.
Demers MF; Fortier L; Corbeil O; Breault AS; Roy MA
Asian J Psychiatr; 2020 Feb; 48():101541. PubMed ID: 30314715
[No Abstract] [Full Text] [Related]
8. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
[TBL] [Abstract][Full Text] [Related]
9. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
10. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
Corbeil O; Béchard L; Fournier É; Plante M; Thivierge MA; Lafrenière CÉ; Huot-Lavoie M; Brodeur S; Essiambre AM; Roy MA; Demers MF
J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
[TBL] [Abstract][Full Text] [Related]
11. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
Silva E; Higgins M; Hammer B; Stephenson P
BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
[TBL] [Abstract][Full Text] [Related]
12. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
13. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
Chan KSW; Lai NBW; Wong MMC; Pang PF
East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
[TBL] [Abstract][Full Text] [Related]
14. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
15. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
Mathewson KA; Lindenmayer JP
J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
[No Abstract] [Full Text] [Related]
16. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F
Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
[No Abstract] [Full Text] [Related]
17. Lithium and clozapine rechallenge: a retrospective case analysis.
Kanaan RA; Kerwin RW
J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
[TBL] [Abstract][Full Text] [Related]
18. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW
Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
[TBL] [Abstract][Full Text] [Related]
20. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
